Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Sáez-Cirión A, Mamez AC, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P, Decosterd L, Hentzien M, Perdomo-Celis F, Salgado M, Nijhuis M, Mélard A, Gardiennet E, Lorin V, Monceaux V, Chapel A, Gourvès M, Lechartier M, Mouquet H, Wensing A, Martinez-Picado J, Yerly S, Rougemont M, Calmy A. Sáez-Cirión A, et al. Among authors: yerly s. Nat Med. 2024 Dec;30(12):3544-3554. doi: 10.1038/s41591-024-03277-z. Epub 2024 Sep 2. Nat Med. 2024. PMID: 39222660 Free PMC article.
Clinical relevance of cytomegalovirus viraemia(*,†).
El Amari EB, Combescure C, Yerly S, Calmy A, Kaiser L, Hasse B, Furrer H, Cavassini M, Vernazza P, Hirsch H, Bernasconi E, Hirschel B; Swiss HIV Cohort Study. El Amari EB, et al. Among authors: yerly s. HIV Med. 2011 Aug;12(7):394-402. doi: 10.1111/j.1468-1293.2010.00900.x. Epub 2011 Jan 19. HIV Med. 2011. PMID: 21251182 Free article.
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J. Wagner N, et al. Among authors: yerly s. New Microbes New Infect. 2015 Feb 27;6:1-4. doi: 10.1016/j.nmni.2015.02.003. eCollection 2015 Jul. New Microbes New Infect. 2015. PMID: 26082840 Free PMC article. Review.
HIV-Positive-to-HIV-Positive Liver Transplantation.
Calmy A, van Delden C, Giostra E, Junet C, Rubbia Brandt L, Yerly S, Chave JP, Samer C, Elkrief L, Vionnet J, Berney T; Swiss HIV and Swiss Transplant Cohort Studies. Calmy A, et al. Among authors: yerly s. Am J Transplant. 2016 Aug;16(8):2473-8. doi: 10.1111/ajt.13824. Epub 2016 Jun 7. Am J Transplant. 2016. PMID: 27109874 Free article.
Determinants of HIV-1 broadly neutralizing antibody induction.
Rusert P, Kouyos RD, Kadelka C, Ebner H, Schanz M, Huber M, Braun DL, Hozé N, Scherrer A, Magnus C, Weber J, Uhr T, Cippa V, Thorball CW, Kuster H, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Fellay J, Regoes RR, Günthard HF, Trkola A; Swiss HIV Cohort Study. Rusert P, et al. Among authors: yerly s. Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187. Epub 2016 Sep 26. Nat Med. 2016. PMID: 27668936
Time to overcome pretreatment HIV drug resistance.
Yerly S, Calmy A. Yerly S, et al. Lancet Infect Dis. 2018 Mar;18(3):239-240. doi: 10.1016/S1473-3099(17)30709-0. Epub 2017 Nov 30. Lancet Infect Dis. 2018. PMID: 29198912 Free article. No abstract available.
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
Glass TR, Günthard HF, Calmy A, Bernasconi E, Scherrer AU, Battegay M, Steffen A, Böni J, Yerly S, Klimkait T, Cavassini M, Furrer H. Glass TR, et al. Among authors: yerly s. Clin Infect Dis. 2021 Apr 26;72(8):1413-1421. doi: 10.1093/cid/ciaa239. Clin Infect Dis. 2021. PMID: 32157270 Free article.
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
Sculier D, Wandeler G, Yerly S, Marinosci A, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd LA, Günthard HF, Schmid P, Limacher A, Egger M, Calmy A; Swiss HIV Cohort Study (SHCS). Sculier D, et al. Among authors: yerly s. PLoS Med. 2020 Nov 10;17(11):e1003421. doi: 10.1371/journal.pmed.1003421. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33170863 Free PMC article. Clinical Trial.
A highly virulent variant of HIV-1 circulating in the Netherlands.
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C; Netherlands ATHENA HIV Observational Cohort†; BEEHIVE Collaboration†. Wymant C, et al. Science. 2022 Feb 4;375(6580):540-545. doi: 10.1126/science.abk1688. Epub 2022 Feb 3. Science. 2022. PMID: 35113714 Free article.
525 results